HTA116 Cost-Effectiveness of Nirmatrelvir/Ritonavir for the Treatment of Outpatient Sars-Cov-2 in Adult Patients at Risk for Developing Severe Disease in Greece
| Autor: | Kalogeropoulou, M., Barmpouni, M., Grammelis, V., Rousakis, A., Livieratos, A., Paraskevis, D., Zisimopoulou, O. |
|---|---|
| Zdroj: | In Value in Health December 2023 26(12) Supplement:S340-S341 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect